Haim Belmaker
Prof. Robert Haim Belmaker, is an Israeli psychiatrist who has had major academic positions in Israeli psychiatry since 1974. He had a formative influence on biological directions in Israeli psychiatry. He was Hoffer-Vickar Professor of Psychiatry at Ben-Gurion University of the Negev, Beersheva Israel until his retirement and is now Emeritus.
He was President of the International College of Neuropsychopharmacology 2008–2010, President of the Israel Psychiatry Association 2015–2018, and Organizing Chair of the World Psychiatric Association Congress on Psychiatry and Religion held in Jerusalem, Israel in December 2019 He has contributed editorials in the areas of treatment of bipolar disorder in 2007 and then in 2014 on antipsychotic treatment of bipolar disorder, on the potential of transcranial magnetic stimulation as a new frontier and on the future of randomised clinical trials. An oral history of his research contributions is available at the American College of Neuropsychopharmacology video archives
Education
Prof. Belmaker received his BA from Harvard College in 1967; his MD from Duke Medical School in 1971; and was a Clinical Fellow at US National Institute of Mental Health 1972–1974.Research focus/interests
Prof. Belmaker has researched the mechanism of action of lithium in bipolar disorder throughout his career and focussed interest on second messenger systems in the brain, Biological Psychiatry, 1993, New England Journal of Medicine,. He was one of the first psychiatrists to study a continuum between the molecular genetics of temperament and that of bipolar disorder and edited a seminal volume. He was one of the first investigators to see the potential for transcranial magnetic stimulation of the brain as a treatment for depression, the first to study it in animal models of depression, and co-edited the first handbook of this treatment for psychiatric disorder that was widely influential for many years. In 2023 Springer Nature published his text "Psychopharmacology Reconsidered: A Concise Text Exploring the Limits of Diagnosis and Treatment", the first textbook of psychopharmacology to emphasize the absence of any biological test for any psychiatric disorder, the lack of correlation between DSM-5 diagnoses and psychopharmacologic indication and mechanisms, high placebo response rates, and indications for withdrawing psychopharmacological treatment.Appointments
1. President of the International College of Neuropsychopharmacology 2008–20102. Vice-president of the International Society for Bipolar Disorders 2012–2014
3. President of the Israel Psychiatric Association 2015–2018
4. President of the International Neuropsychiatry Association 2016–2018
5. Deputy Director of the Mental Health Center in Beersheba 1994–2012
Published works
''''Books
- Robert Haim Belmaker, Pesach Lichtenberg, Psychopharmacology Reconsidered - A Concise Guide Exploring the Limits of Diagnosis and Treatment, Springer, 2023
Articles
- Transcranial magnetic stimulation: a potential new frontier in psychiatry, Biological Psychiatry 38, 1995
- Treatment of bipolar depression, New England Journal of Medicine, 356, 2007
- Lurasidone and bipolar disorder, American Journal of Psychiatry, 171, 2014
- Editorial: the future of randomised clinical trials, Israel Journal of Psychiatry and Related Sciences, 52, 2015
Collaborative works
- .
- .
- .
- George & Belmaker, Transcranial Magnetic Stimulation in Neuropsychiatry. Washington DC: APA Press, 2000.
- Benjamin, Ebstein & Belmaker, Molecular Genetics and Human Personality, Washington DC: APA Press, 2002.
Awards